The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health effects linked to medicines, vaccines, cosmetics, animal food and other consumer products. The FDA Adverse Event Monitoring System (AEMS) began operation Tuesday and will consolidate outdated systems used to











